FIIs Nibble Back: India's Market Sees Foreign Capital Return Amidst Sectoral Crosswinds

STOCK-INVESTMENT-IDEAS
Whalesbook Logo
AuthorRiya Kapoor|Published at:
FIIs Nibble Back: India's Market Sees Foreign Capital Return Amidst Sectoral Crosswinds
Overview

Foreign institutional investors (FIIs) have resumed net buying in Indian equities in February 2026, injecting approximately ₹4,900.17 crore, a notable reversal from the ₹1.66 lakh crore in outflows witnessed throughout 2025. This renewed interest, catalyzed by the finalization of the India-US trade agreement and a robust domestic economic outlook, signals a potential exit from a consolidation phase. However, the return is selective, with headwinds in the IT and pharmaceutical sectors and intense competition in banking requiring careful navigation. India's strong projected GDP growth at 6.4% in FY27 underscores its appeal as a key emerging market, yet global economic slowdown and past valuation concerns necessitate a discerning investment approach.

### Foreign Capital Re-engagement

Foreign institutional investors (FIIs) have initiated a return to Indian equity markets in February 2026, marking net inflows of approximately ₹4,900.17 crore to date. This development follows a challenging 2025, which saw net outflows totaling ₹1.66 lakh crore, and a sustained selling phase between October 2021 and March 2023 where FIIs divested over ₹2.4 lakh crore. The recent re-engagement is reportedly buoyed by the conclusion of a significant trade agreement between India and the United States, which has eased geopolitical uncertainty and potentially lowered tariffs. This influx contrasts with earlier periods when India's relatively high valuations and global uncertainties prompted a "Buy China, Sell India" sentiment among investors. Domestic institutional investors (DIIs) have played a crucial counterbalancing role, investing over ₹3 lakh crore in 2025 and demonstrating continued confidence. The current FII buying, while positive, appears selective rather than a broad market endorsement.

### Sectoral Dynamics: Navigating Crosswinds

While the overall sentiment has improved, specific sectors present a mixed narrative. The banking sector is poised for stability, with Moody's Ratings maintaining a stable outlook, citing India's robust economic growth and resilient asset quality. System-wide loan growth is projected to accelerate modestly to 11-13% in FY27, supported by strong GDP forecasts and improving net interest margins. However, intensifying competition for deposits remains a significant challenge for banks.

The Information Technology (IT) sector, a traditional strength, faces evolving dynamics. Indian IT firms continue to hold a competitive edge globally due to aggressive pricing and lower overheads. Valuations remain attractive compared to international peers. Yet, headwinds from Artificial Intelligence (AI) advancements are creating pressure, potentially impacting stock performance. Furthermore, the sector faces challenges in deep-tech R&D funding and a perceived lag in developing globally dominant products, with many top talents seeking opportunities abroad.

In pharmaceuticals, revenue growth is projected to be healthy at 7-9% in FY26, driven by robust domestic demand and strong European exports. However, the critical US market presents moderating growth prospects, with an expected 3-5% expansion compared to nearly 10% in FY25. This slowdown is attributed to persistent pricing pressures, ongoing regulatory scrutiny, and the potential risk of US tariffs. The sector's strategic shift towards higher-value products and global partnerships is a key trend.

### Emerging Market Benchmarking & Global Context

Emerging markets (EMs) are projected to lead global economic growth in 2026, with EMs expected to grow approximately 4% versus 1.5% for advanced economies. India is highlighted as a market poised to benefit from expanding digital ecosystems. This growth trajectory positions India favorably within the global landscape, which faces a projected slowdown to 2.7% global output in 2026. EMs are demonstrating stronger macroeconomic policy frameworks and anchored inflation expectations, converging with developed market characteristics. However, global trade tensions, fiscal strains, and persistent uncertainty cloud the broader outlook. India's own market valuations, with the BSE Sensex P/E at 23.1 and Nifty 50 P/E around 22.8, suggest a premium that requires justification through sustained earnings growth.

### Forensic Bear Case (Risks)

The cautious optimism surrounding India warrants scrutiny. The return of FII capital appears selective, focusing on specific themes rather than broad market participation, which could lead to increased volatility if sentiment shifts. The pharmaceutical sector's reliance on the US market exposes it to significant risks from potential tariff impositions and ongoing regulatory challenges. In the IT sector, the ongoing AI revolution and a historical focus on services over product innovation pose long-term competitive hurdles against global giants. The banking sector, while stable, faces intense competition for deposits, which could pressure margins. Furthermore, past FII outflows have demonstrated the market's vulnerability to tightening global liquidity and rising bond yields, indicating that the current inflows are not immune to external shocks. A substantial outflow of nearly $10 billion was recorded in October 2024, driven by concerns over India's valuation relative to peers like China.

### Forward Outlook

India's economy is projected to exhibit the fastest GDP growth among G-20 nations at 6.4% in FY27. This strong domestic growth forms the bedrock for market performance, with EMs expected to deliver approximately 14% earnings growth in 2026. While specific sector challenges and global uncertainties persist, the underlying structural tailwinds, coupled with renewed foreign investor interest and robust domestic demand, suggest continued resilience. A long-term perspective, focusing on earnings-driven opportunities and careful risk assessment, will be paramount for investors navigating this evolving market.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.